147 related articles for article (PubMed ID: 26637767)
1. Hodgkin lymphoma in children and adolescents: improving the therapeutic index.
Kelly KM
Hematology Am Soc Hematol Educ Program; 2015; 2015():514-21. PubMed ID: 26637767
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin lymphoma in children and adolescents: improving the therapeutic index.
Kelly KM
Blood; 2015 Nov; 126(22):2452-8. PubMed ID: 26582374
[TBL] [Abstract][Full Text] [Related]
3. Standard therapies versus novel therapies in Hodgkin lymphoma.
Gallamini A; Di Raimondo F; La Nasa G; Romano A; Borra A; Greco M
Immunol Lett; 2013; 155(1-2):56-9. PubMed ID: 24140162
[TBL] [Abstract][Full Text] [Related]
4. Management of children with high-risk Hodgkin lymphoma.
Kelly KM
Br J Haematol; 2012 Apr; 157(1):3-13. PubMed ID: 22188115
[TBL] [Abstract][Full Text] [Related]
5. Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents.
Giulino-Roth L; Keller FG; Hodgson DC; Kelly KM
Br J Haematol; 2015 Jun; 169(5):647-60. PubMed ID: 25824371
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of Hodgkin lymphoma in children, adolescents, and young adults.
Belsky JA; Hochberg J; Giulino-Roth L
Best Pract Res Clin Haematol; 2023 Mar; 36(1):101445. PubMed ID: 36907636
[TBL] [Abstract][Full Text] [Related]
7. Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma.
Harker-Murray PD; Drachtman RA; Hodgson DC; Chauvenet AR; Kelly KM; Cole PD
Pediatr Blood Cancer; 2014 Apr; 61(4):579-86. PubMed ID: 24504790
[TBL] [Abstract][Full Text] [Related]
8. Pediatric Hodgkin Lymphoma.
Mauz-Körholz C; Metzger ML; Kelly KM; Schwartz CL; Castellanos ME; Dieckmann K; Kluge R; Körholz D
J Clin Oncol; 2015 Sep; 33(27):2975-85. PubMed ID: 26304892
[TBL] [Abstract][Full Text] [Related]
9. Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
Eroglu C; Kaynar L; Orhan O; Keklik M; Sahin C; Yildiz OG; Mentes S; Kurnaz F; Aslan D; Sivgin S; Soyuer S; Eser B; Cetin M; Unal A
Am J Clin Oncol; 2015 Feb; 38(1):68-73. PubMed ID: 23563207
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin lymphoma in Tyrol-a population-based study.
Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
[TBL] [Abstract][Full Text] [Related]
11. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
13. Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study group.
Böll B; Goergen H; Arndt N; Meissner J; Krause SW; Schnell R; von Tresckow B; Eichenauer DA; Sasse S; Fuchs M; Behringer K; Klimm BC; Naumann R; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2013 Dec; 31(35):4431-7. PubMed ID: 24190119
[TBL] [Abstract][Full Text] [Related]
14. Adolescent and young adult Hodgkin lymphoma: Raising the bar through collaborative science and multidisciplinary care.
Kahn JM; Kelly KM
Pediatr Blood Cancer; 2018 Jul; 65(7):e27033. PubMed ID: 29603618
[TBL] [Abstract][Full Text] [Related]
15. Optimal therapy of advanced Hodgkin lymphoma.
Advani R
Hematology Am Soc Hematol Educ Program; 2011; 2011():310-6. PubMed ID: 22160051
[TBL] [Abstract][Full Text] [Related]
16. Classic Hodgkin Lymphoma in Adolescents and Young Adults.
Kelly KM; Friedberg JW
J Clin Oncol; 2024 Feb; 42(6):653-664. PubMed ID: 37983570
[TBL] [Abstract][Full Text] [Related]
17. Lymphoma in Adolescents and Young Adults.
Brugières L; Brice P
Prog Tumor Res; 2016; 43():101-14. PubMed ID: 27595360
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
[TBL] [Abstract][Full Text] [Related]
19. Current considerations in AYA Hodgkin lymphoma.
Crombie JL; LaCasce AS
Br J Haematol; 2019 Jan; 184(1):72-81. PubMed ID: 30460695
[TBL] [Abstract][Full Text] [Related]
20. Does the addition of involved field radiotherapy to high-dose chemotherapy and stem cell transplantation improve outcomes for patients with relapsed/refractory Hodgkin lymphoma?
Kahn S; Flowers C; Xu Z; Esiashvili N
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):175-80. PubMed ID: 20732769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
